electroCore, Inc.
Close on Oct 19, 2026
- Market cap
- $71.75K
- P/E (TTM)
- –
- Dividend yield
- –
About electroCore
Electromedical & Electrotherapeutic Apparatus, SIC 3845
electroCore, Inc. is a bioelectronic technology company that develops and markets non-invasive bioelectronic devices and medical solutions. The company operates through two primary product categories: personal-use prescription medical devices for managing conditions such as primary headache and fibromyalgia, and personal-use consumer products designed to promote general wellness and human performance. Key prescription offerings include gammaCore, a non-invasive vagus nerve stimulation device for primary headache conditions, and the wearable Quell Fibromyalgia neuromodulation device. Consumer-oriented offerings include Truvaga for wellness and TAC-STIM for military and professional operational performance. The company serves patients through healthcare providers and commercial channels, with major institutional customers including the U.S. Department of Veterans Affairs, the U.S. Department of Defense, and the U.K. National Health Service.
The company operates primarily in the United States and select international markets, including the United Kingdom. It maintains facility operations and executive offices in Rockaway, New Jersey.
Summary of the business section of electroCore's latest annual report, written by StockData.
Company profile
Company
- Legal name
- electroCore, Inc.
- Headquarters
- Rockaway, NJ
- Address
- 200 Forge Way, Suite 205 07866
- Phone
- (973) 290-0097
- Employees
- 83, Dec 31, 2025
- Industry
- Electromedical & Electrotherapeutic Apparatus
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- Auditor
- Marcum llp, New York, NY
Stock & identifiers
- Ticker
- ECOR
- Exchange
- Nasdaq
- IPO date
- Jun 25, 2018
- Shares outstanding
- 9M, Jul 31, 2026
- Public float
- $27.95M, Jun 30, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-15 reverse, Feb 15, 2023
- SEC CIK
- 1560258
- CUSIP
- 28531P202
- ISIN
- US28531P2020
- LEI
- 5493005O3QC5QV2L2186
- EIN
- 20-3454976
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Michael Fox | See Remarks | 130,000 |
| Joshua S. Lev | See Remarks | 139,889 |
| Thomas J. Errico | Director | 619,467 |
| Elena Bonfiglioli | Director | 41,672 |
| Patricia Wilber | Director | 83,448 |
| Julie Ann Goldstein | Director | 112,510 |
| James Charles Theofilos | Director | 34,670 |
| John P. Gandolfo | Director | 99,221 |
| Thomas M. Patton | Director | 102,782 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Daniel Goldberger | $1.64M | $226.17K | $707.48K | $116 | – |
| FY2024 Daniel Goldberger | $1.62M | $2.69M | $600.70K | $420 | – |
| FY2023 Daniel Goldberger | $1.28M | $1.34M | $679.29K | $154 | – |
| FY2022 Daniel Goldberger | $997.61K | $796.73K | $614.83K | $44 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“of February 1, 2026, we employed 83 full-time employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 2, 2025 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Apr 3, 2025 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Feb 23, 2023 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Dec 23, 2022 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jun 23, 2022 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Dec 23, 2021 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Jul 2, 2020 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Mar 31, 2020 | Deregistration | Termination of SEC registration (Form 15) |
| Jun 25, 2018 | IPO | Initial public offering priced (424B4 prospectus) |
| Jun 20, 2018 | Name change | Name changed from ElectroCore, LLC to electroCore, Inc. |
| Jun 18, 2018 | Listing | Registration of securities on an exchange (Form 8-A) |